Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4
NCT ID: NCT00910130
Last Updated: 2009-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
End Stage Renal Disease
Patients suffering from End Stage Renal Disease on Hemodialysis, without Diabetes
No interventions assigned to this group
Control
Healthy people, with normal Renal Function and without Diabetes, matched with "ESRD group" for age, gender, BMI
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal Renal Function for "Control group"
Exclusion Criteria
* Malnutrition
* Malignancy
* Acute Infection
* Chronic Active Infection
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione IRCCS Policlinico San Matteo di Pavia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Unit Of Nephrology, Dialysis And Transplantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giovanni Piotti, MD
Role: PRINCIPAL_INVESTIGATOR
Unit Of Nephrology, Dialysis And Transpantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy
Teresa Rampino, MD
Role: STUDY_DIRECTOR
Unit Of Nephrology, Dialysis And Transpantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy
Antonio Dal Canton, MD
Role: STUDY_CHAIR
Unit Of Nephrology, Dialysis And Transpantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Giovanni Piotti
Pavia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Giovanni Piotti, MD
Role: primary
Teresa Rampino, MD
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005 Jul 21;436(7049):356-62. doi: 10.1038/nature03711.
Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006 Jun 15;354(24):2552-63. doi: 10.1056/NEJMoa054862.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RBP4
Identifier Type: -
Identifier Source: org_study_id